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Table 1. Incidence of side effects
Side effects 1ST % (Number) 2ND% (Number) 3RD % (Number) 4TH % (Number) 5TH % (Number) 6TH % (Number)
Number of Patient 16 (100%) 16 (100%) 16 (100%) 16 (100%) 16 (100%) 16 (100%)
Fever & chils 4 (25%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Nausea & vomiting 0 (0%) 0 (0%) 1 (6%) 0 (0%) 0 (0%) 0 (0%)
Rash & pruritis 2 (12%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Angioedema 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Bronchospasm 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Dyspnoea 1 (6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Tumor pain 2 (12%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Pre-med
Hydrocortisone 100MG 100MG 100MG 100MG 100MG 100MG
Piriton 10MG 10MG 10MG 10MG 10MG 10MG
Paracetamol 1 GR 1 GR 1 GR 1 GR 1 GR 1 GR
Has infusion rate had to be slowed? 4 (25%) 1 (6%) 1 (6%) 0 (0%) 0 (0%) 0 (0%)
Stopped and d/c? 1 (6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Dexametasone instead of hydrocortisone 3 (19%) 3 (19%) 3 (19%) 3 (19%) 2 (12%) 1 (6%)
Methyl pred 1 G 1 (6%) 1 (6%) 1 (6%) 1 (6%) 1 (6%) 1 (6%)
Repeat pre med 2 (12%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
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UNIT-BASED CARE FOR STEM CELL TRANSPLANT (SCT) PATIENTS
REQUIRING NON INVASIVE VENTILATOR ASSISTANCE
Secola, R., Townsend, P., Killen, R. Childrens Hospital Los Angeles, Los
Angeles, CA
Stem cell transplant (SCT) recipients are part of a markedly im-
munocompromised group of patients receiving myeloablative and
intense immunosuppressive therapies. Respiratory complications
are observed throughout this process and may lead to mechanical
ventilation and transfer to an intensive care unit (ICU). Significant
morbidity and mortality is associated with these patients requiring
mechanical ventilation (Gruson et al, 1999). A less invasive means
of providing respiratory support while maintaining expert care on
the unit would appear to be beneficial. Non invasive ventilation
can offer effective respiratory support and improved gas exchange
for pediatric hematologic patients in respiratory failure (Pisastra
et al, 2004). It may also offer prevention of respiratory failure while
allowing the patients to receive optimal stem cell transplant care.
A multidisciplinary team within a licensed SCT unit took initiative
to assess the need and feasibility of maintaining patients requiring
non invasive ventilation defined as continuous positive airway pres-
sure (CPAP) or bi-level positive airway pressure (BiPAP). After
two months of collaboration with the SCTmedical director, clinical
manager, pulmonologist, intensivist, respiratory clinical manager
and therapists, a policy and procedure was developed as well as
a plan for nursing competence. The priorities included reassessment
of unit workflow and patient aggregation, clinical indications and
criteria for non invasive ventilated assistance on the SCT unit. A
nurse CPAP/BiPAP competency checklist was developed. Respira-
tory care experts shared a CPAP/BiPAP ‘‘cheat’’ sheet and provided
ongoing nursing education including in-services and hands-on dem-
onstrations for 41 unit based registered nurses. All necessary CPAP/
BiPAP equipment was stocked and is maintained in SCT unit supply
area by materials management staff. To date, two patients on BiPAP
have been cared for and maintained on the SCT unit. Ongoing reas-
sessment for any changes in CPAP/BiPAP settings or in cardiopul-
monary status on noninvasive ventilation is required to determine
if ICU care is warranted.587
QUALITY IMPROVEMENT PROCESS FOR ADVANCED PRACTICE PROFES-
SIONALS AND CREDENTIALED SKILLS
Hoffman, L.M., Krugh, D. James Cancer Hospital and Solove Research
Institute, Columbus, OH
Purpose: The purpose of this project was to assess the quality of
bone marrow aspiration and biopsies performed, possible factors
contributing to this quality, and therefore to diagnostic use.
Background: For most patients, bone marrow biopsy is a dreaded
procedure, potentially causing both physical pain and anxiety. It is
also an essentail tool in the diagnosis and classification of many he-matologic and non-hematologic diseases. As more Advanced Prac-
tice Professionals routinely perform this procedure, it is essential
to determine that their methods yield the highest quality data for in-
terpretation.
Method: Bone marrow aspiration and biopsies (n 5 121) from 23
different practitioners were evaluated for patient diagnosis, clinical
history, position at the time of sampling, body mass index, timing
of sample during treatment plan, and role of staff member. Adequacy
of the sample was determined by a Hematopathologist.
Results: 16%of bonemarrow aspiration and 19.2% of bonemarrow
biopsies were considered inadequate, although 100% were inter-
preted by the Hematopathologist. Inadequate bone marrow aspira-
tion was associated with a higher patient BMI (p 5 0.015) and
lower bone marrow cellularity (p 5 0.0001). Inadequate bone mar-
row biopsy was not affected by the patient’s BMI (p 5 0.85), degree
of bone marrow cellularity (p 5 0.75), and there was no correlation
(R2 5 0.02) between patient’s BMI and biopsy core length. Bone
marrow biopsy mean/median length was 10mm, with 12% being
considered inadequate length (\5mm), 11.7% fragmented and
14.2% having aspiraton artifact. 48% of inadequate bonemarrow bi-
opsies were noted to have cortical boone, cartilage and/or bone. No
other factors were causative for an inadequate specimen. Overall Ad-
vance Practice Professional performance was equal to or better than
other levels of practitioner.
Conclusions: Advanced Practice Professionals contribute greatly to
the care of patients with cancer, in small part, by the procedures they
become skilled at performing. Bone marrow aspiration and biopsy is
a significant tool in the arsenal used for assessment of these diseases.
It is critical that optimal specimens be provided to aid in critical
treatment decisions. A quality improvement process, such as one
used in this project, can be utilized for any advanced level procedure
to assure that quality specimens are obtained, and ultimately correct
decisions are made in patient care.588
USE OF TOPICAL CIDOFOVIR FOR THE TREATMENT OF RESISTANT HER-
PES SIMPLEX VIRAL INFECTIONS IN POST ALLOGENEIC HEMATOPOIETIC
STEM CELL TRANSPLANT PATIENTS: TWO CASE REPORTS
Trevino, C.M., Westmoreland, M.D., Hosing, C. Univeristy of Texas
M.D. Anderson Cancer Center, Houston, TX
Post allogeneic hematopoietic stem cell transplant patients are at
risk for the development of infections due to their immuncompro-
mised state. The probability of reactivation of herpes simplex infec-
tions is more than 70 percent post transplantation [1]. Current
standard treatment modalities include the use of intravenous, oral,
and topical medications. The current American Society of Bone
Marrow Transplantation Society guidelines for managing resistant
herpes simplex infections recommend Foscarnet as the treatment
of choice with Cidofovir as an alternative [2]. There are times how-
ever, when the herpes simplex virus will develop resistance to the cur-
rent standard therapy and require the initiation of novel treatment
